Targeted Intraceptor Nanoparticle for Neovascular Macular Degeneration: Preclinical Dose Optimization and Toxicology Assessment.
Zhang X, Bohner A, Bhuvanagiri S, Uehara H, Upadhyay AK, Emerson LL, Bondalapati S, Muddana SK, Fang D, Li M, Sandhu Z, Hussain A, Carroll LS, Tiem M, Archer B, Kompella U, Patil R, Ambati BK.
Zhang X, et al. Among authors: upadhyay ak.
Mol Ther. 2017 Jul 5;25(7):1606-1615. doi: 10.1016/j.ymthe.2017.01.014. Epub 2017 Feb 22.
Mol Ther. 2017.
PMID: 28236576
Free PMC article.